PubMed

Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells.

Vetter ML, D'Aquila RT.

J Virol. 2009 Sep;83(17):8646-54. Epub 2009 Jun 17.PMID: 19535442 [PubMed - indexed for MEDLINE]Related articles

Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity.

Vetter ML, Johnson ME, Antons AK, Unutmaz D, D'Aquila RT.

PLoS Pathog. 2009 Feb;5(2):e1000292. Epub 2009 Feb 6.PMID: 19197360 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals.

Charles M, Noel F, Leger P, Severe P, Riviere C, Beauharnais CA, Miller E, Rutledge J, Bang H, Shealey W, D'Aquila RT, Gulick RM, Johnson WD Jr, Wright PF, Pape JW, Fitzgerald DW.

Bull World Health Organ. 2008 Dec;86(12):970-7.PMID: 19142298 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.

Rebeiro PF, Kheshti A, Bebawy SS, Stinnette SE, Erdem H, Tang YW, Sterling TR, Raffanti SP, D'Aquila RT.

Clin Infect Dis. 2008 Nov 15;47(10):1354-7.PMID: 18922071 [PubMed - indexed for MEDLINE]Related articlesFree article

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.

Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT.

Virology. 2008 Jul 20;377(1):49-53. Epub 2008 May 21.PMID: 18499212 [PubMed - indexed for MEDLINE]Related articlesFree article

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.

Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer WA 3rd, Shikuma C, Johnson VA, Fiscus SA, D'Aquila RT, Schackman BR, Acosta EP, Gulick RM.

J Infect Dis. 2008 Mar 15;197(6):867-70.PMID: 18269317 [PubMed - indexed for MEDLINE]Related articles

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK.

J Infect Dis. 2008 Feb 1;197(3):411-9.PMID: 18248304 [PubMed - indexed for MEDLINE]Related articles

Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.

Motsinger AA, Ritchie MD, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, Johnson VA, Pollard RB, Merigan TC, Hirsch MS, Donahue JP, Kim RB, Haas DW.

Pharmacogenet Genomics. 2006 Nov;16(11):837-45.PMID: 17047492 [PubMed - indexed for MEDLINE]Related articles

Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.

Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, D'Aquila RT, Unutmaz D, Benson CA, Ritchie MD, Landay A; AIDS Clinical Trials Group.

J Infect Dis. 2006 Oct 15;194(8):1098-107. Epub 2006 Sep 6.PMID: 16991084 [PubMed - indexed for MEDLINE]Related articles

Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, De Gruttola V, Pollard RB, Merigan TC, Hirsch MS, George AL Jr, Donahue JP, Kim RB.

J Infect Dis. 2005 Dec 1;192(11):1931-42. Epub 2005 Nov 1.PMID: 16267764 [PubMed - indexed for MEDLINE]Related articles

Update of the drug resistance mutations in HIV-1: 2004.

Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD.

Top HIV Med. 2004 Oct-Nov;12(4):119-24. Review. No abstract available. PMID: 15516709 [PubMed - indexed for MEDLINE]Related articlesFree article

The Role of Baseline HIV-1 Resistance Testing in Patients with Established Infection.

Chan SY, Hulgan T, D'Aquila RT.

Curr Infect Dis Rep. 2004 Jun;6(3):243-249.PMID: 15142489 [PubMed - as supplied by publisher]Related articles

Drug resistance mutations in HIV-1.

Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD; International AIDS Society-USA Drug Resistance Mutations Group.

Top HIV Med. 2003 Nov-Dec;11(6):215-21. Review.PMID: 14724329 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidant stress is increased during treatment of human immunodeficiency virus infection.

Hulgan T, Morrow J, D'Aquila RT, Raffanti S, Morgan M, Rebeiro P, Haas DW.

Clin Infect Dis. 2003 Dec 15;37(12):1711-7. Epub 2003 Nov 19.PMID: 14689356 [PubMed - indexed for MEDLINE]Related articles

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

Shafer RW, Smeaton LM, Robbins GK, De Gruttola V, Snyder SW, D'Aquila RT, Johnson VA, Morse GD, Nokta MA, Martinez AI, Gripshover BM, Kaul P, Haubrich R, Swingle M, McCarty SD, Vella S, Hirsch MS, Merigan TC; AIDS Clinical Trials Group 384 Team.

N Engl J Med. 2003 Dec 11;349(24):2304-15.PMID: 14668456 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.

Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dubé MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS; AIDS Clinical Trials Group 384 Team.

N Engl J Med. 2003 Dec 11;349(24):2293-303.PMID: 14668455 [PubMed - indexed for MEDLINE]Related articlesFree article

Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.

Hulgan T, Donahue JP, Hawkins C, Unutmaz D, D'Aquila RT, Raffanti S, Nicotera F, Rebeiro P, Erdem H, Rueff M, Haas DW.

J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):119-26.PMID: 14526200 [PubMed - indexed for MEDLINE]Related articles

Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection.

Hanna GJ, Balaguera HU, Freedberg KA, Werner BG, Steger Craven KA, Craven DE, D'Aquila RT.

J Infect Dis. 2003 Oct 1;188(7):986-91. Epub 2003 Sep 10.PMID: 14513418 [PubMed - indexed for MEDLINE]Related articles

Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy.

De Pasquale MP, Leigh Brown AJ, Uvin SC, Allega-Ingersoll J, Caliendo AM, Sutton L, Donahue S, D'Aquila RT.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):37-44.PMID: 14501791 [PubMed - indexed for MEDLINE]Related articles

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.

Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Richman DD; International AIDS Society-USA Resistance Testing Guidelines Panel.

Top HIV Med. 2003 Jul-Aug;11(4):150-4.PMID: 12876334 [PubMed - indexed for MEDLINE]Related articlesFree article

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.

Martinez-Picado J, Negredo E, Ruiz L, Shintani A, Fumaz CR, Zala C, Domingo P, Vilaró J, Llibre JM, Viciana P, Hertogs K, Boucher C, D'Aquila RT, Clotet B; SWATCH Study Team.

Ann Intern Med. 2003 Jul 15;139(2):81-9.PMID: 12859157 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug resistance mutations in HIV-1.

D'Aquila RT, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD.

Top HIV Med. 2003 May-Jun;11(3):92-6. No abstract available. PMID: 12837968 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD.

Clin Infect Dis. 2003 Jul 1;37(1):113-28. Epub 2003 Jun 23.PMID: 12830416 [PubMed - indexed for MEDLINE]Related articles

Drug Resistance Mutations in HIV-1.

D'Aquila RT; International AIDS Society-USA, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD.

Top HIV Med. 2002 Nov;10(5):21-25. No abstract available. PMID: 12717052 [PubMed - as supplied by publisher]Related articlesFree article

Accuracy of the TRUGENE HIV-1 genotyping kit.

Grant RM, Kuritzkes DR, Johnson VA, Mellors JW, Sullivan JL, Swanstrom R, D'Aquila RT, Van Gorder M, Holodniy M, Lloyd Jr RM Jr, Reid C, Morgan GF, Winslow DL.

J Clin Microbiol. 2003 Apr;41(4):1586-93.PMID: 12682149 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection.

Tremblay CL, Hicks JL, Sutton L, Giguel F, Flynn T, Johnston M, Sax PE, Walker BD, Hirsch MS, Rosenberg ES, D'Aquila RT.

AIDS. 2003 May 2;17(7):1086-9.PMID: 12700462 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.

Tierney C, Lathey JL, Christopherson C, Bettendorf DM, D'Aquila RT, Hammer SM, Katzenstein DA.

J Infect Dis. 2003 Jan 1;187(1):144-8. Epub 2002 Dec 13.PMID: 12508159 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.

Stone DR, Corcoran C, Wurcel A, McGovern B, Quirk J, Brewer A, Sutton L, D'Aquila RT.

Clin Infect Dis. 2002 Oct 1;35(7):883-6. Epub 2002 Sep 11.PMID: 12228827 [PubMed - indexed for MEDLINE]Related articles

The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1).

Olson DP, Scadden DT, D'Aquila RT, De Pasquale MP.

AIDS. 2002 Sep 6;16(13):1743-7.PMID: 12218384 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral resistance testing for clinical management.

Youree BE, D'Aquila RT.

AIDS Rev. 2002 Jan-Mar;4(1):3-12. Review.PMID: 11998782 [PubMed - indexed for MEDLINE]Related articles

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.

Prado JG, Wrin T, Beauchaine J, Ruiz L, Petropoulos CJ, Frost SD, Clotet B, D'Aquila RT, Martinez-Picado J.

AIDS. 2002 May 3;16(7):1009-17.PMID: 11953467 [PubMed - indexed for MEDLINE]Related articles

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.

Lathey JL, Tierney C, Chang SY, D'Aquila RT, Bettendorf DM, Alexander HC, Santini CD, Hughes AM, Barroga CF, Spector SA, Landes JE, Hammer SM, Katzenstein DA.

J Infect Dis. 2001 Dec 1;184(11):1402-11. Epub 2001 Nov 13.PMID: 11709782 [PubMed - indexed for MEDLINE]Related articles

Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo.

Zachary KC, Hanna GJ, D'Aquila RT.

Clin Infect Dis. 2001 Dec 15;33(12):2075-7. Epub 2001 Nov 7.PMID: 11700580 [PubMed - indexed for MEDLINE]Related articles

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D.

JAMA. 2001 Jul 11;286(2):196-207.PMID: 11448283 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.

Hanna GJ, D'Aquila RT.

Clin Infect Dis. 2001 Mar 1;32(5):774-82. Epub 2001 Feb 28. Review.PMID: 11229846 [PubMed - indexed for MEDLINE]Related articles

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

Gulick RM, Smeaton LM, D'Aquila RT, Eron JJ, Currier JS, Gerber JG, Acosta E, Sommadossi JP, Tung R, Snyder S, Kuritzkes DR, Murphy RL; AIDS Clinical Trials Group 373 Study Team.

J Infect Dis. 2001 Mar 1;183(5):715-21. Epub 2001 Jan 30.PMID: 11181147 [PubMed - indexed for MEDLINE]Related articles

Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing.

Kartsonis NA, D'Aquila RT.

Infect Dis Clin North Am. 2000 Dec;14(4):879-99. Review.PMID: 11144643 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral Drug Resistance in HIV-1.

Hanna GJ, D'Aquila RT.

Curr Infect Dis Rep. 1999 Aug;1(3):289-297.PMID: 11095801 [PubMed - as supplied by publisher]Related articles

Marked differences in quantity of infectious human immunodeficiency virus type 1 detected in persons with controlled plasma viremia by a simple enhanced culture method.

Tremblay CL, Giguel F, Merrill DP, Wong JT, Rosenberg E, Kalams S, Walker BD, D'Aquila RT, Hirsch MS.

J Clin Microbiol. 2000 Nov;38(11):4246-8.PMID: 11060100 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.

Brown AJ, Precious HM, Whitcomb JM, Wong JK, Quigg M, Huang W, Daar ES, D'Aquila RT, Keiser PH, Connick E, Hellmann NS, Petropoulos CJ, Richman DD, Little SJ.

J Virol. 2000 Nov;74(22):10269-73.PMID: 11044070 [PubMed - indexed for MEDLINE]Related articlesFree article

Immune control of HIV-1 after early treatment of acute infection.

Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD.

Nature. 2000 Sep 28;407(6803):523-6.PMID: 11029005 [PubMed - indexed for MEDLINE]Related articles

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens.

Gilbert PB, Hanna GJ, De Gruttola V, Martinez-Picado J, Kuritzkes DR, Johnson VA, Richman DD, D'Aquila RT.

AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1325-36.PMID: 11018852 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral resistance during successful therapy of HIV type 1 infection.

Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, Rosenberg E, Gunthard HF, Sutton L, Savara A, Petropoulos CJ, Hellmann N, Walker BD, Richman DD, Siliciano R, D'Aquila RT.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10948-53.PMID: 11005867 [PubMed - indexed for MEDLINE]Related articlesFree article

Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants.

Martinez-Picado J, Savara AV, Shi L, Sutton L, D'Aquila RT.

Virology. 2000 Sep 30;275(2):318-22.PMID: 10998332 [PubMed - indexed for MEDLINE]Related articles

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.

Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Martinez-Picado J, Sutton L, Hazelwood JD, D'Aquila RT.

J Clin Microbiol. 2000 Jul;38(7):2715-21.PMID: 10878069 [PubMed - indexed for MEDLINE]Related articlesFree article

Limits of resistance testing.

D'Aquila RT.

Antivir Ther. 2000 Mar;5(1):71-6. Review.PMID: 10846596 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

Hirsch MS, Brun-Vézinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, Loveday C, Mellors JW, Clotet B, Conway B, Demeter LM, Vella S, Jacobsen DM, Richman DD.

JAMA. 2000 May 10;283(18):2417-26.PMID: 10815085 [PubMed - indexed for MEDLINE]Related articles

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

Eron JJ Jr, Smeaton LM, Fiscus SA, Gulick RM, Currier JS, Lennox JL, D'Aquila RT, Rogers MD, Tung R, Murphy RL.

J Infect Dis. 2000 May;181(5):1622-8. Epub 2000 Apr 26.PMID: 10783117 [PubMed - indexed for MEDLINE]Related articles

Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.

Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Brown AJ, Savara AV, Hazelwood JD, D'Aquila RT.

J Infect Dis. 2000 Mar;181(3):904-11.PMID: 10720511 [PubMed - indexed for MEDLINE]Related articles

Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.

Precious HM, Günthard HF, Wong JK, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD, Leigh Brown AJ.

AIDS. 2000 Jan 7;14(1):31-6.PMID: 10714565 [PubMed - indexed for MEDLINE]Related articles